Mark Cuban asks: Should NBA allow injured players to use HGH if it speeds recovery?

14 Comments

Mark Cuban is a guy who wants data. He expects studies and information to help provide answers. It’s how he runs all his businesses, including the Dallas Mavericks.

But when it comes to potentially using human growth hormone (HGH) — a controversial substance banned by the NBA — to help injured players recover more quickly, there isn’t any data.

In the wake of a weekend where All-Stars Derrick Rose, Andre Iguodala and Marc Gasol went out with injuries — Rose’s likely keeping him out the rest of the season — the topic of if this could help came up again.

Mavericks’ owner Mark Cuban brought up the idea of looking at this at last owners’ meeting. Cuban told Sam Amick of the USA Today he’d like to see more information on the topic.

“The issue isn’t whether I think it should be used,” Cuban told USA TODAY Sports via e-mail. “The issue is that it has not been approved for such use. And one of the reasons it hasn’t been approved is that there have not been studies done to prove the benefits of prescribing HGH for athletic rehabilitation or any injury rehabilitation that I’m aware of. The product has such a huge (public) stigma that no one wants to be associated with it….

“I believe that professional sports leagues should work together and fund studies to determine the efficacy of HGH for rehabbing an injury,” Cuban told USA TODAY Sports. “Working together could lead us from the path of demonizing HGH and even testosterone towards a complete understanding. It could allow us to make a data based decision rather than the emotional decision we are currently making. And if it can help athletes recover more quickly, maybe we can extend careers and have healthier happier players and fans.”

HGH is very controversial, and in Major League Baseball it remains at the heart of lengthy player bans and the PED controversy that has tainted that sport. The NBA has not had high profile PED cases, but it doesn’t test for HGH right now (that is something the league and players’ union have yet to come to an agreement on, it requires blood tests). To think that NBA players would not use HGH designer PEDs when tens of millions of dollars in contracts are on the line is naïve.

However, should the NBA consider allowing it in specific circumstances is another question. The FDA only allows the use of HGH for a few specific treatments, primarily children whose growth is stunted.

There are difficult ethical questions here, something Amick gets into.

The NBA also is sensitive to the ethical part of the discussion, as the idea that some players would return from injury sooner than others because they were willing to take a drug that may have adverse side effects raises serious concerns about maintaining a level playing field. The possible side effects, according to the FDA, include an increased risk of cancer, nerve pain and elevated cholesterol and glucose levels. If anything, the NBA is moving closer to cracking down on HGH use of any kind.

It’s hard to see a scenario where the NBA switches course and starts to allow HGH use in any specific circumstance. Still, Cuban at least wants the discussion on the table — and he wants some information on whether it would even work for injury recovery.

Bulls claim PG Kay Felder off waivers

Jason Miller/Getty Images
Leave a comment

The Bulls’ point-guard position is a quagmire.

Kris Dunn and Cameron Payne are both injured (and not necessarily good). Jerian Grant is maybe an adequate backup pressed into starting. Ryan Arcidiacono is on a two-way contract.

Enter Kay Felder.

Bulls release:

The Chicago Bulls announced today that the team has waived forward Jarell Eddie and center Diamond Stone, and claimed guard Kay Felder off waivers.

Felder was waived by the Hawks, who acquired him in a salary-dump trade from the Cavaliers. Cleveland drafted Felder No. 54 last year, but ran out of roster spots this year.

Felder is only a moderate prospect. He impressed in the D-League, but at 5-foot-9, he has significant limitations. (His size also makes him incredibly fun to watch when he gets rolling.)

For Chicago, he’s a quite-noteworthy addition.

LeBron James: ‘I still got Pandora with commercials’

1 Comment

Dwyane Wade revealed last year that LeBron James refuses to use his phone internationally unless he’s on Wi-Fi.

LeBron’s friend and new Cavaliers teammate again brought up that claim, and LeBron confirmed – then went even further about his own cheapness.

LeBron in a joint interview with Wade on ESPN:

No. I’m not doing that. I’m not turning on data roaming. I’m not buying no apps. I still got Pandora with commercials.

LeBron – he’s just like us!

As funny as that line is, keep watching to see LeBron hilariously explain how his hairline affects his interviews.

PBT Extra: LeBron as MVP and other NBA postseason award predictions

Leave a comment

Last year, Russell Westbrook had a historic season on his way to the MVP award, with James Harden and Kawhi Leonard right on his heels. But heading into this season, the dynamic for MVP — and many of the NBA awards — feels very different and wide open.

In this latest PBT Extra, I lay out my preseason predictions for every award — LeBron James for MVP, Ben Simmons for Rookie of the Year, and on down the list. There are a few leaps and surprises in there (predicting Most Improved or Sixth Man before the season is a crap shoot, so why not gamble).

Now the predictions season is over, let’s get on to the games.

Jazz: Dante Exum undergoing surgery after shoulder injury

Mike Ehrmann/Getty Images
2 Comments

Jazz point guard Dante Exum hurt his shoulder in a preseason game – an injury that immediately looked like it could be season-ending.

Though Utah doesn’t outright say Exum is done for the year, this doesn’t engender much hope.

Jazz release:

The following is a medical update on Utah Jazz guard Danté Exum who suffered a separated left shoulder on October 6 vs. Phoenix.

After further evaluation, Exum (6-6, 190, Australia) has elected to undergo surgery to stabilize the AC joint of his left shoulder. The surgery is scheduled to take place Tuesday, October 24 in Los Angeles. Further updates will be provided when appropriate.

Exum (obviously) didn’t receive a contract extension before today’s deadline, so he’ll become a free agent next summer. After one full missed season already and two years of limited effectiveness, it’s not even clear Utah will extend Exum a qualifying offer to make him a restricted free agent. The former No. 5 pick almost certainly won’t meet the starter criteria, which means his qualifying offer would be worth $4,333,931 (down from $6,619,903 based on his draft slot).

The Jazz will start Ricky Rubio, and Raul Neto will be the primary point guard behind him. Wings Rodney Hood, Alec Burks, Donovan Mitchell and Joe Ingles can all share facilitating duties.

Utah will probably be just fine without Exum this season, which speaks to his marginal place long-term.